Literature DB >> 9990039

Specificities of CD40 signaling: involvement of TRAF2 in CD40-induced NF-kappaB activation and intercellular adhesion molecule-1 up-regulation.

H H Lee1, P W Dempsey, T P Parks, X Zhu, D Baltimore, G Cheng.   

Abstract

Several tumor necrosis factor receptor-associated factor (TRAF) family proteins including TRAF2, TRAF3, TRAF5, and TRAF6, as well as Jak3, have been implicated as potential mediators of CD40 signaling. An extensive in vitro binding study indicated that TRAF2 and TRAF3 bind to the CD40 cytoplasmic tail (CD40ct) with much higher affinity than TRAF5 and TRAF6 and that TRAF2 and TRAF3 bind to different residues of the CD40ct. Using CD40 mutants incapable of binding TRAF2, TRAF3, or Jak3, we found that the TRAF2-binding site of the CD40ct is critical for NF-kappaB and stress-activated protein kinase activation, as well as the up-regulation of the intercellular adhesion molecule-1 (ICAM-1) gene, whereas binding of TRAF3 and Jak3 is dispensable for all of these functions. Overexpression of a dominantly active IkappaBalpha strongly inhibited CD40-induced NF-kappaB activation, ICAM-1 promoter activity, and cell-surface ICAM-1 up-regulation. These studies suggest a potential signal transduction pathway from the CD40 receptor to the transcriptional activation of the ICAM-1 gene.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9990039      PMCID: PMC15478          DOI: 10.1073/pnas.96.4.1421

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Involvement of CRAF1, a relative of TRAF, in CD40 signaling.

Authors:  G Cheng; A M Cleary; Z S Ye; D I Hong; S Lederman; D Baltimore
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

2.  A novel RING finger protein interacts with the cytoplasmic domain of CD40.

Authors:  H M Hu; K O'Rourke; M S Boguski; V M Dixit
Journal:  J Biol Chem       Date:  1994-12-02       Impact factor: 5.157

3.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

4.  Association between IL-6 and CD40 signaling. IL-6 induces phosphorylation of CD40 receptors.

Authors:  E A Clark; G Shu
Journal:  J Immunol       Date:  1990-09-01       Impact factor: 5.422

Review 5.  CD40 ligand and its role in X-linked hyper-IgM syndrome.

Authors:  R E Callard; R J Armitage; W C Fanslow; M K Spriggs
Journal:  Immunol Today       Date:  1993-11

6.  A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40.

Authors:  T Sato; S Irie; J C Reed
Journal:  FEBS Lett       Date:  1995-01-23       Impact factor: 4.124

7.  The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation.

Authors:  T Kawabe; T Naka; K Yoshida; T Tanaka; H Fujiwara; S Suematsu; N Yoshida; T Kishimoto; H Kikutani
Journal:  Immunity       Date:  1994-06       Impact factor: 31.745

8.  CD40 signaling-mediated induction of Bcl-XL, Cdk4, and Cdk6. Implication of their cooperation in selective B cell growth.

Authors:  T Ishida; N Kobayashi; T Tojo; S Ishida; T Yamamoto; J Inoue
Journal:  J Immunol       Date:  1995-12-15       Impact factor: 5.422

Review 9.  The role of CD40 in the regulation of humoral and cell-mediated immunity.

Authors:  F H Durie; T M Foy; S R Masters; J D Laman; R J Noelle
Journal:  Immunol Today       Date:  1994-09

10.  Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B.

Authors:  I Berberich; G L Shu; E A Clark
Journal:  J Immunol       Date:  1994-11-15       Impact factor: 5.422

View more
  18 in total

1.  NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes.

Authors:  H H Lee; H Dadgostar; Q Cheng; J Shu; G Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

Review 2.  NF-kappaB in pancreatic cancer.

Authors:  Guido M Sclabas; Shuichi Fujioka; Christian Schmidt; Douglas B Evans; Paul J Chiao
Journal:  Int J Gastrointest Cancer       Date:  2003

Review 3.  Molecular mechanism and function of CD40/CD40L engagement in the immune system.

Authors:  Raul Elgueta; Micah J Benson; Victor C de Vries; Anna Wasiuk; Yanxia Guo; Randolph J Noelle
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

4.  TRAF2 and TRAF3 independently mediate Ig class switching driven by CD40.

Authors:  Haifa H Jabara; Yu Weng; Tatyana Sannikova; Raif S Geha
Journal:  Int Immunol       Date:  2009-02-19       Impact factor: 4.823

5.  The scaffold protein RACK1 mediates the RANKL-dependent activation of p38 MAPK in osteoclast precursors.

Authors:  Jingjing Lin; Daekee Lee; Yongwon Choi; Soo Young Lee
Journal:  Sci Signal       Date:  2015-06-02       Impact factor: 8.192

6.  CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection.

Authors:  J X Gao; J Madrenas; W Zeng; M J Cameron; Z Zhang; J J Wang; R Zhong; D Grant
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

7.  Tumour-necrosis-factor-receptor-associated factor 6, NF-kappaB-inducing kinase and IkappaB kinases mediate IgE isotype switching in response to CD40.

Authors:  K Brady; S Fitzgerald; P N Moynagh
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

8.  CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily.

Authors:  A G Eliopoulos; C Davies; P G Knox; N J Gallagher; S C Afford; D H Adams; L S Young
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

9.  Transitional B cells exhibit a B cell receptor-specific nuclear defect in gene transcription.

Authors:  Sarah F Andrews; David J Rawlings
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

10.  Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile.

Authors:  M Chin; M Herscovitch; N Zhang; D J Waxman; T D Gilmore
Journal:  Oncogene       Date:  2009-04-20       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.